Search research articles
Contact Us
Filters
Showing results (111-120 of 138) with videos related to
Page
of 14
Sort By:
Inflammatory Bowel Diseases
|
December 17, 2009
Characterization of the novel ST2/IL-33 system in patients with inflammatory bowel disease
Caroll J Beltrán, Lucía E Núñez, David Díaz-Jiménez, et al.
BMC Gastroenterology
|
August 28, 2016
Soluble ST2 is a sensitive clinical marker of ulcerative colitis evolution
David Díaz-Jiménez, Marjorie De la Fuente, Karen Dubois-Camacho, et al.
European Journal of Immunology
|
November 26, 2010
Constant TCR triggering suggests that the TCR expressed on intestinal intraepithelial γδ T cells is functional in vivo
Frano H Malinarich, Elena Grabski, Tim Worbs, et al.
World Journal of Clinical Cases
|
May 10, 2021
Treatment of acute severe ulcerative colitis using accelerated infliximab regimen based on infliximab trough level: A case report
Ana Lorena Sousa de Vasconcelos Garate, Thiara Barcelos Rocha, Luciana Rocha Almeida, et al.
Revista Medica De Chile
|
November 27, 2014
[Inflammatory bowel disease. Experience in 316 patients]
Daniela Simian, Camila Estay, Jaime Lubascher, et al.
Frontiers in Immunology
|
July 19, 2019
Corrigendum: Short Chain Fatty Acids (SCFAs)-Mediated Gut Epithelial and Immune Regulation and Its Relevance for Inflammatory Bowel Diseases
Daniela Parada Venegas, Marjorie K De la Fuente, Glauben Landskron, et al.
Frontiers in Immunology
|
March 28, 2019
Short Chain Fatty Acids (SCFAs)-Mediated Gut Epithelial and Immune Regulation and Its Relevance for Inflammatory Bowel Diseases
Daniela Parada Venegas, Marjorie K De la Fuente, Glauben Landskron, et al.
The American Journal of Case Reports
|
March 28, 2021
Small Intestinal Hemangioma: A Case Report
Rodrigo Fedatto Beraldo, Mariana Barros Marcondes, Daniel Luiz da Silva, et al.
World Journal of Gastroenterology
|
November 1, 2017
Glucocorticosteroid therapy in inflammatory bowel diseases: From clinical practice to molecular biology
Karen Dubois-Camacho, Payton A Ottum, Daniel Franco-Muñoz, et al.
World Journal of Clinical Cases
|
December 14, 2021
Heart failure as an adverse effect of infliximab for Crohn's disease: A case report and review of the literature
Thais Gagno Grillo, Luciana Rocha Almeida, Rodrigo Fedatto Beraldo, et al.
Page
of 14
Search research articles
Search
Showing results (111-120 of 138) with videos related to
Sort By:
Page
of 14
Inflammatory Bowel Diseases
|
December 17, 2009
Characterization of the novel ST2/IL-33 system in patients with inflammatory bowel disease
Caroll J Beltrán, Lucía E Núñez, David Díaz-Jiménez, et al.
BMC Gastroenterology
|
August 28, 2016
Soluble ST2 is a sensitive clinical marker of ulcerative colitis evolution
David Díaz-Jiménez, Marjorie De la Fuente, Karen Dubois-Camacho, et al.
European Journal of Immunology
|
November 26, 2010
Constant TCR triggering suggests that the TCR expressed on intestinal intraepithelial γδ T cells is functional in vivo
Frano H Malinarich, Elena Grabski, Tim Worbs, et al.
World Journal of Clinical Cases
|
May 10, 2021
Treatment of acute severe ulcerative colitis using accelerated infliximab regimen based on infliximab trough level: A case report
Ana Lorena Sousa de Vasconcelos Garate, Thiara Barcelos Rocha, Luciana Rocha Almeida, et al.
Revista Medica De Chile
|
November 27, 2014
[Inflammatory bowel disease. Experience in 316 patients]
Daniela Simian, Camila Estay, Jaime Lubascher, et al.
Frontiers in Immunology
|
July 19, 2019
Corrigendum: Short Chain Fatty Acids (SCFAs)-Mediated Gut Epithelial and Immune Regulation and Its Relevance for Inflammatory Bowel Diseases
Daniela Parada Venegas, Marjorie K De la Fuente, Glauben Landskron, et al.
Frontiers in Immunology
|
March 28, 2019
Short Chain Fatty Acids (SCFAs)-Mediated Gut Epithelial and Immune Regulation and Its Relevance for Inflammatory Bowel Diseases
Daniela Parada Venegas, Marjorie K De la Fuente, Glauben Landskron, et al.
The American Journal of Case Reports
|
March 28, 2021
Small Intestinal Hemangioma: A Case Report
Rodrigo Fedatto Beraldo, Mariana Barros Marcondes, Daniel Luiz da Silva, et al.
World Journal of Gastroenterology
|
November 1, 2017
Glucocorticosteroid therapy in inflammatory bowel diseases: From clinical practice to molecular biology
Karen Dubois-Camacho, Payton A Ottum, Daniel Franco-Muñoz, et al.
World Journal of Clinical Cases
|
December 14, 2021
Heart failure as an adverse effect of infliximab for Crohn's disease: A case report and review of the literature
Thais Gagno Grillo, Luciana Rocha Almeida, Rodrigo Fedatto Beraldo, et al.
Page
of 14